Neuphoria Therapeutics Inc. Delays Q1 2025 Financial Report Due to Documentation Compilation Needs

Reuters
16 May
<a href="https://laohu8.com/S/NEUP">Neuphoria Therapeutics Inc</a>. Delays Q1 2025 Financial Report Due to Documentation Compilation Needs

Neuphoria Therapeutics Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025. The company cited the need for additional time to compile and analyze supporting documentation and to allow its independent registered public accounting firm to complete its review. Neuphoria expects to file the report within the five-day extension period allowed under Rule 12b-25.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuphoria Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-044176), on May 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10